Condition

Cancer of the Breast

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 50 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials50

Recruiting12

Common interventions25

Lead sponsors shown15

Clinical trials

50 shown

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesNCT07619534 · 2026-10-12

Precision Supplemental Imaging in Women With Dense BreastsNCT07277738 · 2026-09-09

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)NCT07067138 · 2026-02-23

Breast Re-irradiation After Second Ipsilateral LumpectomyNCT06867484 · 2025-10-27

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderNCT07072728 · 2025-10-01

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and SatisfactionNCT06981208 · 2025-06-03

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHYNCT06749210 · 2025-02-19

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast CancerNCT05837455 · 2024-05-30

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical PatientsNCT05972343 · 2023-07-26

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity TestingNCT04968964 · 2022-03-07

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreNCT02476786 · 2017-01-17

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerNCT01766297 · 2013-02-01

Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced CardiotoxicityNCT07838649 · 2026-11-01

NOT_YET_RECRUITING

Overcoming Racial Disparities in Screening MammographyNCT07549139 · 2026-10-31

NOT_YET_RECRUITING

Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)NCT06711939 · 2024-12-09

NOT_YET_RECRUITING

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast CancerNCT06471673 · 2024-05-29

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)NCT05716542 · 2023-05-11

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCNCT05191004 · 2022-09-01

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNCT05252390 · 2022-03-29

Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer SettingNCT06595901 · 2022-03-10

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNCT04541225 · 2020-12-08

Real-time Intraoperative Breast Cancer Visualization for Margin AssessmentNCT02807597 · 2020-02-18

Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentNCT02891681 · 2016-11-29

Pre- Versus Postoperative Accelerated Partial Breast IrradiationNCT02913729 · 2016-11-10

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsNCT02669914 · 2016-09-12

Shave Margins in Breast Conservation TherapyNCT02462200 · 2016-06-13

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant ChemotherapyNCT02595372 · 2015-11-12

Bright Light on Fatigue in Women Being Treated for Breast CancerNCT02658708 · 2015-10-12

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour DefectsNCT02302196 · 2015-09-01

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)NCT02580448 · 2015-08-01

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related CancersNCT02396433 · 2015-04-01

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and MelanomaNCT02316795 · 2014-02-01

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)NCT01881230 · 2013-09-26

Proton Radiation for Stage II/III Breast CancerNCT01758445 · 2013-02-01

ACTIVE_NOT_RECRUITING

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerNCT01498588 · 2011-11-01

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast CancerNCT01272141 · 2010-12-01

Study of Pralatrexate in Female Patients With Previously-treated Breast CancerNCT01118624 · 2010-03-01

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerNCT01271738 · 2009-09-01

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresNCT00832338 · 2009-04-01

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast CancerNCT00817362 · 2009-03-01

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyNCT00661531 · 2008-04-01

Multipeptide Vaccine for Advanced Breast CancerNCT00573495 · 2007-11-01

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast CancerNCT00530868 · 2007-10-08

Axillary Reverse MappingNCT00572481 · 2007-05-01

ACTIVE_NOT_RECRUITING

Sentinel Node Biopsy and Axillary Sampling in Operable Breast CancerNCT00128362 · 2005-09-01

Preliminary Study of Mycograb and Docetaxel in Advanced Breast CancerNCT00217815 · 2005-09-01

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at PresentationNCT00193778 · 2005-02-01

Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operationNCT00571987 · 2004-09-01

A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseNCT00191373 · 2002-03-01

A Phase III Trial For Patients With Metastatic Breast CancerNCT00191152 · 2002-02-01

Common interventions

Leading sponsors

Washington University School of Medicine15 Emory University4 Nuvation Bio Inc.3 Eli Lilly and Company2 National Cancer Institute (NCI)2 Proton Collaborative Group2 Tata Memorial Hospital2 University of Arkansas2 Acrotech Biopharma Inc.1 BriaCell Therapeutics Corporation1 Celgene1 Georgetown University1 Infinity Pharmaceuticals, Inc.1 Innocrin Pharmaceutical1 Kaiser Permanente1

Trial status mix

COMPLETED18

RECRUITING12

TERMINATED12

NOT_YET_RECRUITING3

ACTIVE_NOT_RECRUITING2

WITHDRAWN2

UNKNOWN1

Phase mix

PHASE227

PHASE112

NA11

PHASE32

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.